This site uses cookies to store information on your computer. Learn more x

Consensus Figures

A number of international financial analysts cover DSM. The most recent consensus figures – provided by Vara Research – are detailed below. The figures are based on the estimates given by the banks that were approached by Vara Research.

Analysts' consensus Q2 2017 and FY 2017 published 16 June 2017

  Q2 2016 FY 2016 Q2 2017 E FY 2017 E
Sales (continuing)        
  Number of Estimates     21 21
  Highest     2,200 8,571
  Consensus 1,994 7,920 2,139 8,456
  Median     2,139 8,465
  Lowest     2,060 8,158
EBITDA (continuing)        
  Number of Estimates     21 22
  Highest     366 1,427
  Consensus 328 1,262 354 1,375
  Median     354 1,374
  Lowest     337 1,305
EBIT (continuing)        
  Number of Estimates     19 22
  Highest     249 948
  Consensus 211 791 233 886
  Median     233 889
  Lowest     221 816
Nutrition, Sales        
  Number of Estimates     21 21
  Highest     1,420 5,623
  Consensus 1,295 5,169 1,372 5,468
  Median     1,366 5,471
  Lowest     1,310 5,249
Nutrition, EBITDA        
  Number of Estimates     21 22
  Highest     267 1,067
  Consensus 237 931 257 1,013
  Median     257 1,015
  Lowest     245 966
Nutrition, EBIT        
  Number of Estimates     19 21
  Highest     197 776
  Consensus 165 645 184 719
  Median     182 722
  Lowest     175 669
Materials, Sales        
  Number of Estimates     21 21
  Highest     730 2,818
  Consensus 640 2,513 706 2,740
  Median     704 2,743
  Lowest     675 2,599
Materials, EBITDA        
  Number of Estimates     21 22
  Highest     132 481
  Consensus 117 435 122 459
  Median     121 458
  Lowest     114 439
Materials, EBIT        
  Number of Estimates     19 21
  Highest     95 355
  Consensus 86 311 89 331
  Median     88 331
  Lowest     83 307
Innovation Center, Sales        
  Number of Estimates     21 21
  Highest     47 185
  Consensus 40 167 43 175
  Median     43 175
  Lowest     40 169
Innovation Center, EBITDA        
  Number of Estimates     21 22
  Highest     3 12
  Consensus 0 1 1 6
  Median     1 6
  Lowest     -1 -2
Innovation Center, EBIT        
  Number of Estimates     19 21
 Highest     -3 -14
  Consensus -5 -24 -5 -20
  Median     -5 -20
  Lowest     -7 -27
Corporate Activities, Sales        
  Number of Estimates     21 21
  Highest     20 77
  Consensus 19 71 19 72
  Median     19 72
  Lowest     17 68
Corporate Activities, EBITDA        
  Number of Estimates     21 22
  Highest     -23 -93
  Consensus -26 -105 -26 -103
  Median     -26 -103
  Lowest     -30 -110
Corporate Activities, EBIT        
  Number of Estimates     19 21
  Highest     -31 -133
  Consensus -35 -141 -35 -141
  Median     -35 -141
  Lowest     -43 -150
Profit for the period, before exceptional items - Cont. Ops.        
  Number of Estimates     18 20
  Highest     189.8 713
  Consensus 135.0 508.0 169.3 642
  Median     169.8 640
  Lowest     150.3 532
Net EPS before exceptional items - Cont. Ops.        
  Number of Estimates     18 20
  Highest     1.08 4
  Consensus 0.76 2.89 0.96 4
  Median     0.96 4
  Lowest     0.85 3

DSM Disclaimer

Consensus earnings estimates are based on earnings projections made by securities analysts who cover DSM. Any opinions, forecasts, estimates, projections or predictions regarding DSM’s performance made by the analysts (and, therefore, the Consensus estimate numbers) are theirs alone and do not represent the opinions, forecasts, estimates, projections or predictions of DSM or its management. DSM does not by providing these estimates imply its endorsement of or concurrence with such information, conclusions or recommendations. DSM assumes no liability for the accuracy of such estimates and undertakes no obligation to update or revise such estimates.